← SynDRA
GSK163090
SynDRA canonical compound SYN0025853 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR1A | HTR1B | HTR1D |
|---|
| Mechanism of action | serotonin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- HTR1A ANTAGONIST
- Serotonin 1a (5-HT1a) receptor antagonist
- HTR1B ANTAGONIST
- Serotonin 1b (5-HT1b) receptor antagonist
- HTR1D ANTAGONIST
- Serotonin 1d (5-HT1d) receptor antagonist
- SLC6A4 ANTAGONIST
- Serotonin transporter antagonist
- serotonin receptor antagonist
Cross-references
Synonyms
- GSK-163090
- GSK 163090
- UNII-7XI927X82B
- CHEMBL1631540
- 7XI927X82B
- 1-(3-(2-(4-(2-Methyl-5-quinolinyl)-1-piperazinyl)ethyl)phenyl)-2-imidazolidinone
- 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone
- 1-[3-[2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl]phenyl]-2-imidazolidinone
- ANGUXJDGJCHGOG-UHFFFAOYSA-N
- SCHEMBL2881345
- DTXSID30233480
- EX-A1027
- BCP16941
- ZINC34451922
- BDBM50333015
- AKOS030526918
- CS-5315
- HY-14348
- RefChem:782733
- MFCD18782711
- orb1296061
- SCHEMBL29766953
- C25H29N5O
- TQ0311
- GSK163090?
- AC-33679
- FG145140
- MS-27223
- DS-016438
- BRD-K69669039-001-01-8
- gsk-163090
- SCHEMBL2905331
- GSK163090 (dihydrochloride)
- NYZRWDMGYQYXEQ-UHFFFAOYSA-N
Look up GSK163090 in the interactive SynDRA portal →